These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28393669)

  • 21. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment.
    Bottos M; Benedetti MG; Salucci P; Gasparroni V; Giannini S
    Dev Med Child Neurol; 2003 Nov; 45(11):758-62. PubMed ID: 14580131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of serial casting on lower limb function for children with Cerebral Palsy: a systematic review with meta-analysis.
    Milne N; Miao M; Beattie E
    BMC Pediatr; 2020 Jul; 20(1):324. PubMed ID: 32615954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy.
    Colovic H; Dimitrijevic L; Stankovic I; Nikolic D; Radovic-Janosevic D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):41-7. PubMed ID: 22580859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of addition of botulinum toxin-A to standardized therapy for dynamic manual skills measured with kinematic aiming tasks in children with spastic hemiplegia.
    Rameckers EA; Duysens J; Speth LA; Vles HJ; Smits-Engelsman BC
    J Rehabil Med; 2010 Apr; 42(4):332-8. PubMed ID: 20461335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients.
    Carda S; Invernizzi M; Baricich A; Cisari C
    Clin Rehabil; 2011 Dec; 25(12):1119-27. PubMed ID: 21729974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report.
    Kwon JY; Hwang JH; Kim JS
    Am J Phys Med Rehabil; 2010 Apr; 89(4):279-86. PubMed ID: 20068435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement.
    Love SC; Novak I; Kentish M; Desloovere K; Heinen F; Molenaers G; O'Flaherty S; Graham HK;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():9-37. PubMed ID: 20633177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children.
    Kanellopoulos AD; Mavrogenis AF; Mitsiokapa EA; Panagopoulos D; Skouteli H; Vrettos SG; Tzanos G; Papagelopoulos PJ
    Eur J Phys Rehabil Med; 2009 Dec; 45(4):501-6. PubMed ID: 20032908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
    Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
    Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of botulinum toxin type-A injection on spasticity, range of motion and gait patterns in children with spastic diplegic cerebral palsy: an Egyptian study.
    El-Etribi MA; Salem ME; El-Shakankiry HM; El-Kahky AM; El-Mahboub SM
    Int J Rehabil Res; 2004 Dec; 27(4):275-81. PubMed ID: 15572990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
    Dai AI; Aksoy SN; Demiryürek AT
    J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Botulinum toxin A and physical therapy in gait in cerebral palsy].
    García-Sánchez SF; Gómez-Galindo MT; Guzmán-Pantoja JE
    Rev Med Inst Mex Seguro Soc; 2017; 55(1):18-24. PubMed ID: 28092243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy-A Secondary Analysis of the Randomized Clinical Trial.
    Hong BY; Chang HJ; Lee SJ; Lee S; Park JH; Kwon JY
    Toxins (Basel); 2017 Aug; 9(8):. PubMed ID: 28825663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy.
    Fattal-Valevski A; Giladi N; Domanievitz D; Zuk L; Masterman R; Harel S; Wientroub S; Hayek S
    J Child Neurol; 2002 Apr; 17(4):272-7. PubMed ID: 12088083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin-A with and without rehabilitation for the treatment of spastic cerebral palsy.
    Jianjun L; Shurong J; Weihong W; Yan Z; Fanyong Z; Nanling L
    J Int Med Res; 2013 Jun; 41(3):636-41. PubMed ID: 23696596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with botulinum toxin in the treatment of cerebral palsy.
    Arens LJ; Leary PM; Goldschmidt RB
    S Afr Med J; 1997 Aug; 87(8):1001-3. PubMed ID: 9323408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
    Balbaloglu O; Basaran A; Ayoglu H
    J Child Neurol; 2011 Apr; 26(4):482-7. PubMed ID: 21270468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.